Veru (VERU) Expected to Announce Earnings on Thursday

Veru (NASDAQ:VERU - Get Free Report) is expected to be posting its quarterly earnings results before the market opens on Thursday, February 6th. Analysts expect Veru to post earnings of ($0.08) per share and revenue of $3.02 million for the quarter.

Veru (NASDAQ:VERU - Get Free Report) last released its earnings results on Monday, December 16th. The company reported ($0.06) EPS for the quarter, beating the consensus estimate of ($0.07) by $0.01. Veru had a negative net margin of 223.85% and a negative return on equity of 92.88%. On average, analysts expect Veru to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Veru Trading Down 3.3 %

VERU stock traded down $0.02 during trading on Thursday, reaching $0.59. 4,031,516 shares of the stock were exchanged, compared to its average volume of 6,337,272. The stock has a 50 day simple moving average of $0.75 and a 200-day simple moving average of $0.80. Veru has a twelve month low of $0.36 and a twelve month high of $1.92. The company has a market capitalization of $86.51 million, a P/E ratio of -2.13 and a beta of -0.53.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on VERU. HC Wainwright reissued a "buy" rating and issued a $3.00 price target on shares of Veru in a report on Thursday, January 2nd. Oppenheimer reiterated an "outperform" rating and issued a $5.00 price target on shares of Veru in a research report on Tuesday, November 5th.

About Veru

Veru Inc, a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). Its marketed products comprise FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections.